Lalaca capsule 75mg
Each capsule contains Pregabalin 75mg
Red cap and white body hard gelatin capsule containing white or pale yellow powders
- treatment of neuropathic pain associated with central and peripheral neuropathy
- adjunctive treatment of partial epileptic seizures in adults
- treatment of fibromyalgia
Dosage and administration
Lalaca is given orally with or without food.
This drug is not recommended to children under 12 years old and adolescent
Patient with hypersensitivity to pregabalin or any of its components
Patients who have genetic problem to galactose intolerance, Lapp lactase deficiency, glucosegalactose malaabsorption because lalaca contains lacotse
Diabetes patients who gained weight when pregabalin was administered
These have been postmarketing reports of angioedema in patient during initial and chronic treatment with pregabalin. Specific symptoms included selling of the face, mouth (tongue, lips and gums), and neck (throat and larynx). Discontinue Lalaca immediately in patients with these symptoms
Age person : Pregabalin may cause dizziness, somnolence when aged people was administrate.
In controlled studies, a higher proportion of patients treated with Lalaca reported blurred vision temporarily, this symptom will be reduced if patients stop taking pregabalin